Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
Company announcement No. 50 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 39, 2026) Copenhagen, Denmark, September 28, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
To keep drug prices high, pharma has been piling up the patents
The cost of healthcare in general is a debilitating, pre-existing condition for Americans. But the high prices of prescription drugs usually stand out as a pain point. While there are many insidious reasons why Americans pay more—often far…
Lilly CEO Eyes Bigger Deals in Hunt for Pharma's 'White Spaces'
Investors should expect Eli Lilly & Co. to strike slightly larger deals, along the lines of its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as it casts a wide net for assets in the “white spaces” of science, Chief…
Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596
HRS-1596 is a phase 1-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales royalties Bagsværd, Denmark…
Roche Focuses on Speed at Pharma Day
Roche provided a glimpse into its pipeline at its “Pharma Day.” (File photo) At its so-called “Pharma Day,” Roche sent a clear message to the market: The company intends to remain a top player. This applies to both the…
India Gets US Pharma Tariff Exemption, But Which Drugs Still Face Trump's 100% Duty?
Washington: The United States has exempted select pharmaceutical products and related components originating from India and 19 other partner jurisdictions from import duties, even as Washington moves ahead with a 100 per cent tariff on specified…
Why rare-disease drugs could become India's next pharma frontier
Each rare disease affects very few people. However, there are around 8,000 rare diseases, and they cumulatively affect hundreds of millions of people. In India, 1,004 rare genetic disorders have been reported so far. It used to be that because the…
Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug
Sun Pharmaceutical Industries and LIB Therapeutics Inc on Monday announced an exclusive licensing agreement granting the Indian drug maker rights to commercialise and manufacture lerodalcibep worldwide, excluding the U.S. and China. The agreement…
Roche Holding AG (RHHBY) Discusses Pharma Strategy, R&D Excellence, AI in Drug Development, and Pipeline Updates Across Key Therapeutic Areas Transcript
Roche Holding AG (RHHBY) Discusses Pharma Strategy, R&D Excellence, AI in Drug Development, and Pipeline Updates Across Key Therapeutic Areas September 28, 2026 4:30 AM EDT Bruno Eschli - Head of Investor Relations Teresa Graham - Chief Executive…
Natco Pharma raises eGenesis investment to $16.70 million
Natco Pharma Ltd on Monday said it has decided to increase its proposed investment in US-based biotechnology firm eGenesis Inc to USD 16.70 million (around Rs 139 crore) from the previously disclosed amount of USD 14 million. Under the revised…
Anupam Rasayan completes purchase of 48.2 pc stake in Bliss GVS Pharma for ₹1,750 cr
Specialty chemicals maker Anupam Rasayan India on Tuesday said it has completed the acquisition of a 48.2 per cent controlling stake in Bliss GVS Pharma for ₹1,750 crore, marking its push into finished dosage formulations. It is Anupam…
AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs
is investing $2 billion into Summit Therapeutics as part of an expanded partnership between the two companies. Summit said Monday that AstraZeneca will buy $2 billion of convertible preferred shares, representing a common stock price of $18.36 a…
HCAH, QMS merge pharma businesses to expand patient support services
Health Care At Home India Pvt Ltd (HCAH) and QMS Medical Allied Services Ltd (QMS) on Monday announced a strategic merger of their pharma businesses to drive their patient support program for pharmaceutical companies across India. Under the…
Oil, pharma enterprises and banks already migrating from hyperscaler to local cloud service providers: ESDS
Noting the strong push for sovereignty in India, oil, pharmaceutical companies, enterprises and banks have migrated from hyperscaler to local cloud service provider ESDS Software Solutions, as per company CEO Piyush Somani. Unaffected by the…
Torrent Pharma raises investment in Torrent Urja 27 to ₹11.88 cr to acquire 26% stake
Torrent Pharmaceuticals Ltd has increased its proposed investment in Torrent Urja 27 Pvt Ltd to ₹11.88 crore to acquire a 26 per cent stake, following an increase in project capacity, according to a regulatory filing on Monday. The company…
Receive a Daily briefing on Pharma Industry News
Get Started